ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 973

$430K Total Retail Price of All Prescriptions

Rank: 206 out of 973

538 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 538 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,699 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 535 501 1 3
LEVOTHYROXINE SODIUM 524 485 2 2
SIMVASTATIN 511 483 3 1
FUROSEMIDE 498 471 4 6
OMEPRAZOLE 488 441 5 5
HYDROCODONE-ACETAMINOPHEN 354 324 S3 6 4
SERTRALINE HCL 339 328 7 21
LOSARTAN POTASSIUM 306 306 8 19
AMLODIPINE BESYLATE 280 280 9 7
METOPROLOL TARTRATE 261 258 10 13
POTASSIUM CHLORIDE 259 246 11 9
ATENOLOL 246 232 12 16
TAMSULOSIN HCL 220 213 13 28
METFORMIN HCL 215 187 14 8
ALENDRONATE SODIUM 185 184 15 24
METOPROLOL SUCCINATE 182 181 16 17
WARFARIN SODIUM 132 132 17 10
GLIMEPIRIDE 128 115 18 41
LOSARTAN-HYDROCHLOROTHIAZIDE 126 110 19 46
HYDROCHLOROTHIAZIDE 116 111 20 11
GABAPENTIN 108 78 21 12
ATORVASTATIN CALCIUM 106 94 22 15
FINASTERIDE 104 104 23 90
DONEPEZIL HCL 102 102 24 26
POLYETHYLENE GLYCOL 3350 99 87 25 36
CARBIDOPA-LEVODOPA 96 84 26 71
MIRTAZAPINE 94 94 27 43
PANTOPRAZOLE SODIUM 93 89 28 37
ZOLPIDEM TARTRATE 91 77 29 20
AZITHROMYCIN 91 72 29 47
CITALOPRAM HBR 89 60 31 14
MELOXICAM 89 72 31 23
DOXAZOSIN MESYLATE 87 75 33 87
FLUTICASONE PROPIONATE 86 84 34 35
PROPRANOLOL HCL 86 78 34 97
JANTOVEN 83 83 36 113
ALLOPURINOL 82 79 37 29
CYMBALTA 78 63 38 40
TRIAMCINOLONE ACETONIDE 77 73 39 120
DIGOXIN 74 74 40 32
CLOPIDOGREL 72 66 41 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 66 42 25
PLAVIX 70 66 42 78
PRAVASTATIN SODIUM 68 53 44 22
EVISTA 64 64 45 121
LACTULOSE 63 63 46 199
PREDNISONE 62 59 47 33
LEVOFLOXACIN 60 51 48 84
CARVEDILOL 60 60 48 27
ISOSORBIDE MONONITRATE ER 60 49 48 85
NADOLOL 59 59 51 342
AMIODARONE HCL 57 57 52 189
TRIMETHOPRIM 56 56 53 355
DIVALPROEX SODIUM 55 53 54 86
NOVOLOG FLEXPEN 54 29 55 168
RISPERIDONE 53 53 56 65
TRIAMTERENE-HCTZ 52 48 57 51
DIOVAN 51 51 58 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.